These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

393 related articles for article (PubMed ID: 32483108)

  • 1. Fournier's Gangrene and Diabetic Ketoacidosis Associated with Sodium Glucose Co-Transporter 2 (SGLT2) Inhibitors: Life-Threatening Complications.
    Kasbawala K; Stamatiades GA; Majumdar SK
    Am J Case Rep; 2020 Jun; 21():e921536. PubMed ID: 32483108
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sodium-glucose cotransporter-2 (SGLT2) inhibitor-induced euglycemic diabetic ketoacidosis complicating the perioperative management of a patient with type 2 diabetes mellitus (T2DM) and Fournier's gangrene: A case report.
    Lindsay PJ; Gibson LE; Bittner EA; Berg S; Chang MG
    Int J Surg Case Rep; 2020; 77():463-466. PubMed ID: 33395826
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A Case of Fournier's Gangrene in a Patient Taking Canagliflozin for the Treatment of Type II Diabetes Mellitus.
    Elbeddini A; Gallinger J; Davey M; Brassard S; Gazarin M; Plourde F; Aly A
    Am J Case Rep; 2020 Feb; 21():e920115. PubMed ID: 32089542
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Challenging Treatment of a Female Patient with Extensive Fournier's Gangrene - Case Report.
    Kostovski O; Spasovska O; Trajkovski G; Antovic S; Kostovska I; Tosheska-Trajkovska K; Kuzmanovska B; Pejkova S; Jankulovski N
    Prague Med Rep; 2021; 122(1):39-44. PubMed ID: 33646941
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fournier Gangrene Associated With Sodium-Glucose Cotransporter-2 Inhibitors: A Review of Spontaneous Postmarketing Cases.
    Bersoff-Matcha SJ; Chamberlain C; Cao C; Kortepeter C; Chong WH
    Ann Intern Med; 2019 Jun; 170(11):764-769. PubMed ID: 31060053
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fournier's gangrene with dapagliflozin in a rural hospital: a case report.
    Elbeddini A; Tayefehchamani Y; Davey M; Gallinger J; Hooda N; Aly A; Erickson D; Lee S
    BMJ Case Rep; 2021 Feb; 14(2):. PubMed ID: 33526523
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fournier's gangrene in a man on empagliflozin for treatment of Type 2 diabetes.
    Kumar S; Costello AJ; Colman PG
    Diabet Med; 2017 Nov; 34(11):1646-1648. PubMed ID: 28887847
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Management of Fournier's gangrene: an eleven year retrospective analysis of early recognition, diagnosis, and treatment.
    Norton KS; Johnson LW; Perry T; Perry KH; Sehon JK; Zibari GB
    Am Surg; 2002 Aug; 68(8):709-13. PubMed ID: 12206606
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fournier's gangrene in a patient on dapagliflozin treatment for type 2 diabetes.
    Onder CE; Gursoy K; Kuskonmaz SM; Kocer U; Culha C
    J Diabetes; 2019 May; 11(5):348-350. PubMed ID: 30604507
    [No Abstract]   [Full Text] [Related]  

  • 10. Fournier's gangrene and sodium-glucose cotransporter 2 inhibitors: Is there a causal association?
    Bloomgarden Z; Einhorn D; Grunberger G; Handelsman Y
    J Diabetes; 2019 May; 11(5):340-341. PubMed ID: 30600643
    [No Abstract]   [Full Text] [Related]  

  • 11. Fournier's Gangrene as an Adverse Event Following Treatment with Sodium Glucose Cotransporter 2 Inhibitors.
    Suciu IM; Greluș A; Cozlac AR; Suciu BS; Stoica S; Luca S; Luca CT; Gaiță DI
    Medicina (Kaunas); 2024 May; 60(5):. PubMed ID: 38793020
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fournier's gangrene and SGLT2 inhibitors: A case study.
    García-García A; Galeano-Valle F; Nuevo-González JA; Demelo-Rodríguez P
    Endocrinol Diabetes Nutr (Engl Ed); 2020; 67(6):423-425. PubMed ID: 32354633
    [No Abstract]   [Full Text] [Related]  

  • 13. Euglycemic Diabetic Ketoacidosis with Elevated Acetone in a Patient Taking a Sodium-Glucose Cotransporter-2 (SGLT2) Inhibitor.
    Andrews TJ; Cox RD; Parker C; Kolb J
    J Emerg Med; 2017 Feb; 52(2):223-226. PubMed ID: 27717592
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fournier's gangrene under SGLT-2 inhibitor therapy: A literature review and case report.
    Ellegård L; Prytz M
    Int J Surg Case Rep; 2020; 77():692-694. PubMed ID: 33395875
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fournier's gangrene: A retrospective analysis of 25 patients.
    Yücel M; Özpek A; Başak F; Kılıç A; Ünal E; Yüksekdağ S; Acar A; Baş G
    Ulus Travma Acil Cerrahi Derg; 2017 Sep; 23(5):400-404. PubMed ID: 29052826
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A retrospective case series of Fournier's gangrene: necrotizing fasciitis in perineum and perianal region.
    Zhang N; Yu X; Zhang K; Liu T
    BMC Surg; 2020 Oct; 20(1):259. PubMed ID: 33126879
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Euglycemic Diabetic Ketoacidosis with Persistent Diuresis Treated with Canagliflozin.
    Adachi J; Inaba Y; Maki C
    Intern Med; 2017; 56(2):187-190. PubMed ID: 28090050
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Severe Fournier's gangrene in a patient with rectal cancer: case report and literature review.
    Yoshino Y; Funahashi K; Okada R; Miura Y; Suzuki T; Koda T; Yoshida K; Koike J; Shiokawa H; Ushigome M; Kaneko T; Nagashima Y; Goto M; Kurihara A; Kaneko H
    World J Surg Oncol; 2016 Sep; 14(1):234. PubMed ID: 27585438
    [TBL] [Abstract][Full Text] [Related]  

  • 19. SGLT2 Inhibitors and Euglycemic Ketoacidosis.
    Masuta P; Johri G; Paul M
    Am J Ther; 2018; 25(4):e498-e500. PubMed ID: 28537992
    [No Abstract]   [Full Text] [Related]  

  • 20. Fournier's gangrene: experience with 25 patients and use of Fournier's gangrene severity index score.
    Yeniyol CO; Suelozgen T; Arslan M; Ayder AR
    Urology; 2004 Aug; 64(2):218-22. PubMed ID: 15302463
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.